Screening of Unexplored FDA-approved Inactive Ingredients as Stabilizers for Monoclonal Antibody Products. (PubMed, Pharm Res) - Oct 13, 2026 - "Underexplored FDA-approved excipients, particularly isomalt and myo-inositol, improved mAb stability under thermal stress and represent promising candidates for further evaluation during therapeutic antibody formulation development."
FDA event • Journal • Hematological Disorders • HER-2
|
|
Anurag S Rathore; Avinash Mishra; Charu Mittal; Divya Agrawal
|